On the Integration of In Silico Drug Design Methods for Drug Repurposing
Drug repurposing has become an important branch of drug discovery. Several computational approaches that help to uncover new repurposing opportunities and aid the discovery process have been put forward, or adapted from previous applications. A number of successful examples are now available. Overal...
| Published in: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | Eric March-Vila, Luca Pinzi, Noé Sturm, Annachiara Tinivella, Ola Engkvist, Hongming Chen, Giulio Rastelli |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2017-05-01
|
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00298/full |
Similar Items
How drug repurposing can advance drug discovery: challenges and opportunities
by: Luca Pinzi, et al.
Published: (2024-08-01)
by: Luca Pinzi, et al.
Published: (2024-08-01)
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies [version 2; peer review: 2 approved]
by: Luca Pinzi, et al.
Published: (2022-03-01)
by: Luca Pinzi, et al.
Published: (2022-03-01)
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies [version 1; peer review: 2 approved]
by: Luca Pinzi, et al.
Published: (2022-02-01)
by: Luca Pinzi, et al.
Published: (2022-02-01)
Computational polypharmacology comes of age
by: Giulio eRastelli, et al.
Published: (2015-07-01)
by: Giulio eRastelli, et al.
Published: (2015-07-01)
Editorial: Artificial intelligence and machine learning for drug discovery, design and repurposing: methods and applications
by: Pan Zheng, et al.
Published: (2023-11-01)
by: Pan Zheng, et al.
Published: (2023-11-01)
Repurposing antifungal drugs for cancer therapy
by: Ningna Weng, et al.
Published: (2023-06-01)
by: Ningna Weng, et al.
Published: (2023-06-01)
Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2021-11-01)
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2021-11-01)
Applications and prospects of cryo-EM in drug discovery
by: Kong-Fu Zhu, et al.
Published: (2023-03-01)
by: Kong-Fu Zhu, et al.
Published: (2023-03-01)
Role of structure-based drug design (SBDD) in the repurposing and discovery of anti-viral leads against Monkeypox virus disease
by: Jihane Touhtouh, et al.
Published: (2025-07-01)
by: Jihane Touhtouh, et al.
Published: (2025-07-01)
CavitOmiX Drug Discovery: Engineering Antivirals with Enhanced Spectrum and Reduced Side Effects for Arboviral Diseases
by: Lena Parigger, et al.
Published: (2024-07-01)
by: Lena Parigger, et al.
Published: (2024-07-01)
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum
by: Reagan M. Mogire, et al.
Published: (2024-05-01)
by: Reagan M. Mogire, et al.
Published: (2024-05-01)
Potential Benefits of In Silico Methods: A Promising Alternative in Natural Compound’s Drug Discovery and Repurposing for HBV Therapy
by: Samuel Chima Ugbaja, et al.
Published: (2025-03-01)
by: Samuel Chima Ugbaja, et al.
Published: (2025-03-01)
Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives
by: Zixun Wang, et al.
Published: (2025-03-01)
by: Zixun Wang, et al.
Published: (2025-03-01)
Systematic Prediction of Antifungal Drug Synergy by Chemogenomic Screening in Saccharomyces cerevisiae
by: Hamid Gaikani, et al.
Published: (2021-07-01)
by: Hamid Gaikani, et al.
Published: (2021-07-01)
A Guide to In Silico Drug Design
by: Yiqun Chang, et al.
Published: (2022-12-01)
by: Yiqun Chang, et al.
Published: (2022-12-01)
In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)
by: Luca Pinzi, et al.
Published: (2019-07-01)
by: Luca Pinzi, et al.
Published: (2019-07-01)
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
by: Andrés Pizzorno, et al.
Published: (2019-03-01)
by: Andrés Pizzorno, et al.
Published: (2019-03-01)
Using word evolution to predict drug repurposing
by: Judita Preiss
Published: (2024-04-01)
by: Judita Preiss
Published: (2024-04-01)
Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV
by: Mohan Krishna Mallakuntla, et al.
Published: (2022-11-01)
by: Mohan Krishna Mallakuntla, et al.
Published: (2022-11-01)
The importance of in-silico studies in drug discovery
by: Miah Roney, et al.
Published: (2024-08-01)
by: Miah Roney, et al.
Published: (2024-08-01)
Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
by: Mithun Rudrapal, et al.
Published: (2022-12-01)
by: Mithun Rudrapal, et al.
Published: (2022-12-01)
Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
by: Trang T. T. Truong, et al.
Published: (2022-07-01)
by: Trang T. T. Truong, et al.
Published: (2022-07-01)
Drug repurposing in COVID-19: A review with past, present and future
by: Kamna Srivastava, et al.
Published: (2021-12-01)
by: Kamna Srivastava, et al.
Published: (2021-12-01)
A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization
by: Yu Yuan, et al.
Published: (2025-03-01)
by: Yu Yuan, et al.
Published: (2025-03-01)
Artificial intelligence for drug repurposing against infectious diseases
by: Anuradha Singh
Published: (2024-12-01)
by: Anuradha Singh
Published: (2024-12-01)
AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure
by: Ziad Sabry, et al.
Published: (2025-06-01)
by: Ziad Sabry, et al.
Published: (2025-06-01)
Experimental and machine learning-based exploration of repurposed drugs reveals chemical features underlying phospholipidosis
by: Maria Kuzikov, et al.
Published: (2026-04-01)
by: Maria Kuzikov, et al.
Published: (2026-04-01)
DTA Atlas: A massive-scale drug repurposing database
by: Madina Sultanova, et al.
Published: (2024-12-01)
by: Madina Sultanova, et al.
Published: (2024-12-01)
Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
by: Exequiel O. J. Porta, et al.
Published: (2023-07-01)
by: Exequiel O. J. Porta, et al.
Published: (2023-07-01)
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
by: Mario Roberto Senger, et al.
by: Mario Roberto Senger, et al.
Repurposed Drugs in Gastric Cancer
by: Diana Araújo, et al.
Published: (2022-12-01)
by: Diana Araújo, et al.
Published: (2022-12-01)
Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs
by: Georgia Dorahy, et al.
Published: (2023-01-01)
by: Georgia Dorahy, et al.
Published: (2023-01-01)
Network-based drug repurposing for potential stroke therapy
by: Qihui Wu, et al.
Published: (2023-01-01)
by: Qihui Wu, et al.
Published: (2023-01-01)
Identifying Phosphodiesterase‐5 Inhibitors with Drug Repurposing Approach: Implications in Vasodysfunctional Disorders
by: Mohd Shahnawaz Khan, et al.
Published: (2024-05-01)
by: Mohd Shahnawaz Khan, et al.
Published: (2024-05-01)
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR
by: Francesca Foschi, et al.
Published: (2023-12-01)
by: Francesca Foschi, et al.
Published: (2023-12-01)
In Silico Repurposed Drugs against Monkeypox Virus
by: Hilbert Yuen In Lam, et al.
Published: (2022-08-01)
by: Hilbert Yuen In Lam, et al.
Published: (2022-08-01)
In silico approaches for drug repurposing in oncology: a scoping review
by: Bruno Raphael Ribeiro Cavalcante, et al.
Published: (2024-06-01)
by: Bruno Raphael Ribeiro Cavalcante, et al.
Published: (2024-06-01)
Drug Target Interaction Prediction Using Machine Learning Techniques – A Review
by: A. Suruliandi, et al.
Published: (2024-06-01)
by: A. Suruliandi, et al.
Published: (2024-06-01)
Editorial: Drug Repurposing
by: Pan Pantziarka, et al.
Published: (2019-07-01)
by: Pan Pantziarka, et al.
Published: (2019-07-01)
Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
by: Jie Dong, et al.
Published: (2023-12-01)
by: Jie Dong, et al.
Published: (2023-12-01)
Similar Items
-
How drug repurposing can advance drug discovery: challenges and opportunities
by: Luca Pinzi, et al.
Published: (2024-08-01) -
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies [version 2; peer review: 2 approved]
by: Luca Pinzi, et al.
Published: (2022-03-01) -
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies [version 1; peer review: 2 approved]
by: Luca Pinzi, et al.
Published: (2022-02-01) -
Computational polypharmacology comes of age
by: Giulio eRastelli, et al.
Published: (2015-07-01) -
Editorial: Artificial intelligence and machine learning for drug discovery, design and repurposing: methods and applications
by: Pan Zheng, et al.
Published: (2023-11-01)
